ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 1520
    RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
  • Abstract Number: 2238
    RA Medication Preferences Among U.S. Patients in an Online Rheumatoid Arthritis Community
  • Abstract Number: 3120
    RA Net: A Systems Biology Approach to Identify Genes Regulating Pathogenic Pathways in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)
  • Abstract Number: 3110
    Rab4A Is Required for Development of Tregs, Restricts Antiphospholipid Antibody Production and Pro-Inflammatory Expansion of Macrophages and Neutrophils, and Blocks Pristane-Induced Intra-Alveolar Hemorrhage in a Mouse Model of SLE
  • Abstract Number: 2351
    Racial Differences in Magnetic Resonance Image-Based Three-Dimensional Bone Shape of the Knee: Data from the Osteoarthritis Initiative (OAI)
  • Abstract Number: 116
    Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis
  • Abstract Number: 2501
    Radiographic Damage in Patients with RA Increases By 8.3% per Year Disease Duration, in the Era of Biologic Dmards. Results from the Scqm Cohort
  • Abstract Number: 154
    Radiographic Knee Osteoarthritis in Patients Complaining of Knee Pain: Ultrasound Features
  • Abstract Number: 2350
    Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
  • Abstract Number: 716
    Radiographic Progression and Changes in Inflammation and Structural Damage on Serial MRI Examinations over 5 Years in Patients with Ankylosing Spondylitis Treated with TNF-Alpha Inhibitors
  • Abstract Number: 588
    Radiographic Progression Is Less Significant in Anti-Carbamylated Antibody-Positive Patients with Rheumatoid Arthritis (RA) Who Were Clinically Active and Under the Treatment with Biological Dmards
  • Abstract Number: 718
    Radiographic Progression of Hip Arthritis in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors
  • Abstract Number: 2534
    Radiographic Remission in Patients with Seropositive RA at Ten Years after Diagnosis, Treated in a Real Life Setting
  • Abstract Number: 2353
    Radiographic Variations in Hip Morphology Are Associated with Hip Symptoms: A Cross-Sectional Analysis of a Large Community-Based Cohort
  • Abstract Number: 428
    Random Forest Models Using Electronic Health Record Data Are Predictive of One-Year Outcomes in Lupus Nephritis Patients Taking Mycophenolate Mofetil Induction Therapy
  • Abstract Number: 797
    Randomized Clinical Trials of Systemic Lupus Erythematosus: Evaluating Differences in the Enrolled Populations
  • Abstract Number: 1709
    Randomized, Double-Blind Study Comparing Chs-0214 with Etanercept (Enbrel) in Patients with Psoriasis and Psoriatic Arthritis
  • Abstract Number: 2008
    Rapamycin Elicits Rapid and Lasting Improvement of Disease Activity through Blocking Pro-Inflammatory T Cell Lineage Specification in Patients with Active SLE
  • Abstract Number: 1699
    RAPID3 Near Remission Shows Good Agreement with Minimal Disease Activity Criteria in Psoriatic Arthritis
  • Abstract Number: 3123
    Rare Mediterranean Fever (MEFV) Gene Polymorphisms Are Associated with Ankylosing Spondylitis in Turkish and Iranian Population
  • Abstract Number: 1242
    Rate of Hospitalization for Heart Failure Is Lower in Patients with Controlled Gout Versus Uncontrolled Gout
  • Abstract Number: 118
    Rates and Determinants of Persistent Patient-Physician Discordance in Global Assessment of Disease Activity in Latinos with Rheumatoid Arthritis in the United States
  • Abstract Number: 1868
    Rates and Predictors of Physical Therapy and Occupational Therapy Utilization in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study
  • Abstract Number: 931
    Rates of Lipid Testing and Statin Prescriptions Among SLE and Diabetes Mellitus Patients in a Nationwide Medicaid Cohort
  • Abstract Number: 2398
    Reaching the Masses: A Novel Approach to Pediatric Rheumatology Education Via Tele-Learning
  • Abstract Number: 2668
    Real Time Sonoelastography in Primary Sjögren’s Syndrome Correlates with Morphological Ultrasonographic Features and Glandular Activity but Not with Glandular Fibrosis
  • Abstract Number: 2603
    Real World Practice Based Clinical Study of Delayed-Release Prednisone Produces Comparable Results to a Controlled Clinical Trial: Morning Stiffness and Disease Measures in Moderate-Severe RA Patients Switched from Immediate-Release to Delayed Release-Prednisone
  • Abstract Number: 2595
    Real World Results from a Post-Approval Safety Surveillance of Tofacitinib (Xeljanz): Over 3 Year Results from an Ongoing US-Based Rheumatoid Arthritis Registry
  • Abstract Number: 2484
    Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up
  • Abstract Number: 599
    Real World United States-Based Clinical Experience with Prior Biologic Use Among First Time Golimumab Intravenous and Infliximab Treated Rheumatoid Arthritis Patients
  • Abstract Number: 2318
    Real World Use of the Myositis Autoantibody Panel
  • Abstract Number: 2247
    REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
  • Abstract Number: 2228
    Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
  • Abstract Number: 1637
    Real-World Use of Tofacitinib in Rheumatoid Arthritis: Data from the Swiss Clinical Quality Management RA Registry
  • Abstract Number: 2523
    Reasons for Provider Non-Adherence to a Treat to Target Strategy in Rheumatoid Arthritis
  • Abstract Number: 2335
    Recent Changes of Radiological Findings and Patients’ Background of Rheumatoid Hip and Knee
  • Abstract Number: 1987
    Recessive Coding and Regulatory Mutations in FBLIM1 Underlie the Pathogenesis of Sterile Osteomyelitis
  • Abstract Number: 2221
    Recognition of Secondary Fibromyalgia Using an Index of 3 Components of the Multi-Dimensional Health Assessment Questionnaire: 90% Agreement with ACR Criteria for Fibromyalgia
  • Abstract Number: 3071
    Recombinant Human Proteoglycan-4 (rhPRG4) Inhibits Monosodium Urate (MSU) Crystal Phagocytosis By Human Macrophages and Resultant Inflammatory Response
  • Abstract Number: 2510
    Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases
  • Abstract Number: 3115
    Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity
  • Abstract Number: 2148
    Recruitment of Circulating Monocytes By TNF/IL-6-Induced Expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) Drives Valvular Inflammation in K/B/g7 Mice
  • Abstract Number: 1068
    Recurrence of  Thrombosis Despite Negativization of Antiphospholipid Antibodies in Primary Antiphospholipid Syndrome. a Follow-up to 5 Years
  • Abstract Number: 2881
    Reduced Hippocampal-Thalamic Fiber Tracts in Systemic Lupus Erythematosus
  • Abstract Number: 2452
    Reduced Ovarian Reserve in Young Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 1146
    Reducing Imaging Tests for Low Back Pain: Can Patients Choose Wisely?
  • Abstract Number: 2542
    Reducing the Dosage of Glucocorticoid to Zero Might Decrease Risk of Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study
  • Abstract Number: 145
    Reduction in Musculoskeletal Ultrasound (MSK-US) Payments in 2014: Effects & Consequences
  • Abstract Number: 641
    Reduction of Concomitant Oral Methotrexate or Corticosteroids in Combination Treatment with Adalimumab Does Not Affect Effectiveness in Patients with Rheumatoid Arthritis
  • Abstract Number: 1395
    Regional Brain Gray Matter Volume Loss in Children and Adolescents with SLE
  • Abstract Number: 105
    Regional Primary Care Rheumatology Networks for Patients with Rheumatic and Musculoskeletal Diseases: Need for a National Approach
  • Abstract Number: 2735
    Regional Variability of Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: An Analysis from a Prospective, Observational Registry
  • Abstract Number: 2937
    Regulation of Follicular Helper T (TFH) Cells By ROCK2 (Rho-associated coiled-coil containing protein kinase 2)
  • Abstract Number: 2698
    Regulation of Inflammation By Interleukin-27 in a Rat Model of Spondyloarthritis (SpA)
  • Abstract Number: 664
    Regulation of Interferon Signaling By a Calcium-Induced miRNA in Primary Human Salivary Gland Epithelial Cells
  • Abstract Number: 2106
    Regulation of Marginal Zone B Cell Differentiation By microRNA-146a
  • Abstract Number: 2257
    Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation
  • Abstract Number: 1131
    Regulation of Rheumatoid Arthritis Synovial Fibroblast Cytokine Production By Inhibitor of DNA Binding-1 Via Crispr/Cas9 Transfection
  • Abstract Number: 1450
    Regulatory Mechanisms of Mesenchymal Stem Cell Transplantation on Systemic Osteoporosis in Collagen-Induced Arthritis Mice
  • Abstract Number: 1658
    Regulatory Role of  the IL-9/IL-9R System  on Pannus Formation in Psoriatic Arthritis
  • Abstract Number: 3109
    Regulatory T Cells Deficient in Protein Phosphatase 2A Lose Suppressive Function and Convert to an Effector Phenotype
  • Abstract Number: 1927
    Relapses in Patients with ANCA-Associated Vasculitis: A Retrospective Study on Severity and Organ Involvement Compared to Initial Onset
  • Abstract Number: 2340
    Relation Between Range of Motion and Physical Activity While Recovering after Total Knee Replacement
  • Abstract Number: 291
    Relation of Foot Pronation during Walking to Risk of Worsening Lateral Patellofemoral and Medial Tibiofemoral Cartilage Damage
  • Abstract Number: 1980
    Relation of Pain Sensitization to the Evolution from Intermittent to Chronic, Persistent Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 2345
    Relation of Varus Knee Thrust during Walking to Two-Year Incidence of Frequent Ankle, Hip, and Lower Back Pain
  • Abstract Number: 2943
    Relationship Between  Menstruation and Symptoms of Behcet’s Syndrome
  • Abstract Number: 370
    Relationship Between Alcohol Consumption and Symptom Severity in Chronic Pain Patients
  • Abstract Number: 758
    Relationship Between Corticosteroids and Adverse Events in SLE –Data from the Clinical Trial Belimumab in Subjects with Systemic Lupus Erythematosus
  • Abstract Number: 689
    Relationship Between Infliximab Serum Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis
  • Abstract Number: 1572
    Relationship Between KDR (VEGFR2) Gene Polymorphisms and Serum KDR Protein Levels in Patients with Rheumatoid Arthritis
  • Abstract Number: 229
    Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population
  • Abstract Number: 140
    Relationship Between the Prevalence of Subclinical Tenosynovitis and Therapy in Patients with RA in Clinical Remission: Results from Italian Society of Rheumatology Study Group
  • Abstract Number: 2028
    Relationship of Limb Length Inequality and Incident and Progressive Knee and Hip Radiographic Osteoarthritis and Symptoms
  • Abstract Number: 3105
    Relationships Between a Serum Biomarker of B Cell Differentiation and B Cell Activating Factor Suggest Possible Distinct Pathways of Response to Rituximab in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1333
    Relevance of Granulomatous Presentation for the Diagnosis and Outcome of Uveitis: Retrospective Case-Control Study of 251 Patients
  • Abstract Number: 2741
    Reliability and Construct Validity of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire – Independent Validation Study in a UK Cohort
  • Abstract Number: 971
    Reliability and Minimal Clinically Important Differences (MCID) of Forced Vital Capacity: Post-Hoc Analyses from the Scleroderma Lung Studies (SLS-I and II)
  • Abstract Number: 936
    Reliability and Responsiveness of an Omeract Tenosynovitis Magnetic Resonance Imaging Scoring System for the Rheumatoid Arthritis Wrist and Hand
  • Abstract Number: 1261
    Reliability and Validity of the Patient Health Questionnaire-9 for Assessment of Depression in Socioeconomically Disadvantaged Latinos with Rheumatoid Arthritis Living in the United States
  • Abstract Number: 139
    Reliability of Ultrasound in Detecting Cartilage Change in Patients with Rheumatoid Arthritis: A Study By Omeract Ultrasound Task Force
  • Abstract Number: 1888
    Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis
  • Abstract Number: 2466
    Remission According to RAPID3 (routine assessment of patient index data 3) in Patients with Rheumatoid Arthritis: A Cross-Sectional 3 Center Study from Routine Care
  • Abstract Number: 1779
    Remission and Low Lupus Disease Activity Status (LLDAS) Protect Lupus Patients from Damage Occurrence: Data from a Multi-Ethnic, Multinational Latin American Lupus Cohort
  • Abstract Number: 3147
    Remote Inflammation Triggers Autoimmune Arthritis through Th17 Distribution
  • Abstract Number: 966
    Renal Activity in Lupus (RAIL) Urinary Biomarkers Predict Treatment Response
  • Abstract Number: 206
    Renal Safety of Lesinurad: A Pooled Analysis of Phase III and Extension Studies
  • Abstract Number: 443
    Repetitive Requisition of Antinuclear Antibody Testing (ANA) in Outpatient Multispecialty Clinics in Patients with a Known Positive ANA
  • Abstract Number: 120
    Reproductive Tract Infections (RTI) in Indian (Asian) Women of Child Bearing Age Suffering from RA:I Don’t Ask Them, They Don’t Tell Me
  • Abstract Number: 459
    Resident Non-Classical Monocytes Are Critically Important for Tissue Destruction in Arthritis
  • Abstract Number: 2659
    Respiratory Symptoms in Patients with Primary SjöGren’s Syndrome – a Case-Control Study
  • Abstract Number: 1358
    Response of Hidradenitis Suppurativa to Biologic Therapy
  • Abstract Number: 769
    Response to Belimumab in SLE Patients with High Disease Activity: Data from a Multicentric Clinical-Practice Based Study Cohort
  • Abstract Number: 2387
    Response to Pamidronate Treatment Assessed By Whole Body Magnetic Resonance Imaging in Pediatric Chronic Non-Bacterial Osteomyelitis
  • Abstract Number: 3237
    Responsiveness and Its Magnitude in the 36-Item Short Form Health Survey and the Lupus Quality of Life Questionnaire in Patients with Active Disease
  • Abstract Number: 1421
    Responsiveness of Lupus Impact Tracker Among Chinese Patients with Lupus
  • Abstract Number: 2040
    Responsiveness of Patient Reported Outcomes Measurement Information System Measures in RA Patients Starting or Switching a DMARD
  • Abstract Number: 188
    Responsiveness to X-Linked Toll-like Receptors Differs Between Mice with XY and XX Sex Chromosome Complement, Regardless of the Gonadal Sex
  • Abstract Number: 2569
    Restoration of Decreased Lymphocyte Counts and the Shift to Th1 and Effector Memory CD8+T Cell Subsets Associate with Spontaneous Regression of Lympho-Proliferative Disorders Developed in RA Patients Treated with Methotrexate
  • Abstract Number: 2857
    Results from a Phase 0 Longitudinal Clinical Trial in Cutaneous Lupus Erythematosus: Analysis of the Type I IFN Signature in the Skin and Blood and Its Relationship with Disease Activity Scores and Autoantibody Profiles
  • Abstract Number: 2653
    Results of a Comprehensive Review of Pulmonary Function and Safety Data in a Phase IIb Clinical Program Testing Anti-GM-CSF Receptor Antagonist Mavrilimumab for Treatment of RA
  • Abstract Number: 321
    Results of a Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Romosozumab in Men with Osteoporosis
  • Abstract Number: 2483
    Results of a Pilot Study of a Tailored Symptom Assessment Tool to Enhance Patient-Centered Care in Rheumatoid Arthritis:  Choice RA
  • Abstract Number: 2656
    Resume of Biologic Therapy after Tuberculosis Infection in Patients with Inflammatory Arthropathies. Daily Clinical Practice Data from an Endemic Country
  • Abstract Number: 2628
    Retention of Use and Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: A Patient Record Assessment in a Compassionate Use Programme in South Africa, a Tuberculosis Endemic Country
  • Abstract Number: 3031
    Rethinking Primary Sjögren’s Syndrome: Stratification By Clinical Phenotypes to Improve Understanding of Disease Pathogenesis, Trial Design, Clinical Management and Prospective Health Gains?
  • Abstract Number: 929
    Retinal Examinations Among SLE Patients Newly-Initiating Hydroxychloroquine in a U.S. Medicaid SLE Population, 2000-10
  • Abstract Number: 1191
    Retinal Vessel Morphometry Associations with Polymyalgia Rheumatica; Findings from the European Prospective Investigation of Cancer (EPIC) in Norfolk
  • Abstract Number: 923
    Retinoic Acid Inhibits Expression of Interleukin 9 By Altering Enhancer Architecture
  • Abstract Number: 270
    Retinoic Acid-Inducible Gene-I Increased in Peripheral CD3+T Lymphocytes of Patients with Dermatomyositis
  • Abstract Number: 2620
    Retrospective Analysis for Determining the Signs and Symptoms of Infections before They Become Serious in Tocilizumab-Treated RA Patients Using a Postmarketing Adverse Events Reporting Database
  • Abstract Number: 1941
    Retrospective Survey of Concomitant Autoimmune Diseases and Autoantibodies in a Cohort of Patients with ANCA-Associated Vasculitis (AAV)
  • Abstract Number: 783
    Review of SLE Cohort to Identify Predictors of Response to B Cell Depletion in Patients with Active SLE
  • Abstract Number: 1138
    Rheumapalooza Update: Applying a Flipped Classroom Instructional Model to an Intensive Rheumatology Curriculum for Second Year Medical Students
  • Abstract Number: 1341
    Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Literature Review
  • Abstract Number: 1339
    Rheumatic Immune Related Adverse Events of Checkpoint Therapy for Cancer: Case Series of a New Nosologic Entity
  • Abstract Number: 2
    Rheumatoid Arthritis (RA)-Related Autoimmunity and Lumbar Bone Mineral Density in a Multi-Ethnic Community-Dwelling Population
  • Abstract Number: 4
    Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population
  • Abstract Number: 3152
    Rheumatoid Arthritis (RA): Premature Use of Biologics Accelerating in United States (US)
  • Abstract Number: 2652
    Rheumatoid Arthritis and Excess Mortality Associated with Treatments: a Systematic Review and Meta-Analysis
  • Abstract Number: 1549
    Rheumatoid Arthritis and Periodontal Disease: Salivary ACPA Levels and Clinical Presentation
  • Abstract Number: 5
    Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis
  • Abstract Number: 1917
    Rheumatoid Arthritis Cells Produce Extracellular Vesicles That Incorporate PD-1 and microRNAs Targeting the PD-1 Pathway in Surrounding Cells
  • Abstract Number: 2441
    Rheumatoid Arthritis Flares and Pregnancy Outcomes Among Women in a Longitudinal Registry
  • Abstract Number: 1992
    Rheumatoid Arthritis Is an Independent Risk Factor for Increased Insulin Resistance and Impaired Beta-Cell Function: Impact of Disease Activity
  • Abstract Number: 1551
    Rheumatoid Arthritis Is Associated with Low-/Mid-Frequency Hearing Impairment: Data from the Korean National Health and Nutrition Examination Survey
  • Abstract Number: 566
    Rheumatoid Arthritis Patients’ Ability to Accurately Recall DMARD Information Immediately Following an Office Visit with Their Rheumatologist
  • Abstract Number: 1236
    Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs
  • Abstract Number: 26
    Rheumatoid Factor Positivity Increases All-Cause and Cancer Mortality Risk in Korean Healthy Examinees: A Kangbuk Samsung Health Study
  • Abstract Number: 2115
    Rheumatoid Factors May Potentiate Immune Complex Formation of Anti-Citrullinated Protein Antibodies
  • Abstract Number: 3080
    Rheumatologic Consequences of Immunotherapy to Treat Malignancies: The Tip of an Iceberg
  • Abstract Number: 1313
    Rheumatologic Diseases in HIV-Infected Patients in the Post-Antiretroviral Therapy Era: The County Experience
  • Abstract Number: 1418
    Rheumatologist: If You Fell Ill with Seropositive Active Rheumatoid Arthritis Yourself, What to Do!
  • Abstract Number: 101
    Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System
  • Abstract Number: 1149
    Rheumatology Elective Time in a 4+1 Residency Structure: Evaluating Impact of a Novel Residency Schedule Structure on Rheumatology Resident Education
  • Abstract Number: 856
    Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy
  • Abstract Number: 1886
    Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension
  • Abstract Number: 1020
    Risk Factors Can Classify Individuals Who Develop Accelerated Knee Osteoarthritis
  • Abstract Number: 2456
    Risk Factors for Adverse Pregnancy Outcome in Antiphospholipid Antibodies Carriers: Results from a Multicenter Italian Cohort over 20 Years of Experience
  • Abstract Number: 2051
    Risk Factors for Cardiovascular Disease Predate the Onset of Symptoms of Rheumatoid Arthritis
  • Abstract Number: 1773
    Risk Factors for Cerebrovascular Events in Systemic Lupus Erythematosus: Results from an International, Inception Cohort Study
  • Abstract Number: 1181
    Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis
  • Abstract Number: 1798
    Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review
  • Abstract Number: 773
    Risk Factors for Severe Infections in Rituximab Treated Patients: Comparison of Systemic Lupus Erythematosus and Inflammatory Myositis
  • Abstract Number: 2643
    Risk Factors of Pneumocystis Jiroveci Pneumonia (PJP) in Patients with RA and Sulfasalazine As a Possible Protective Agent
  • Abstract Number: 1353
    Risk Factors of Pulmonary Mycobacterium Avium-Comlex (MAC) Disease and the Significance of Anti-MAC Antibody in Patients with Rheumatic Diseases
  • Abstract Number: 2618
    Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in the French Registry Regate (REGISTRY –ROACTEMRA)
  • Abstract Number: 683
    Risk Factors of Uveitis in Ankylosing Spondylitis
  • Abstract Number: 896
    Risk for Cardiovascular Disease in Giant Cell Arteritis and Polymyalgia Rheumatica
  • Abstract Number: 1496
    Risk for Serious Infection in Rheumatoid Arthritis Associated Interstitial Lung Disease
  • Abstract Number: 1714
    Risk of 10-Year Cardiovascular Disease Assessed By Framingham Risk Score Is Similar in Patients with Psoriatic Arthritis and Psoriasis As Assessed By Atherosclerotic Cardiovascular Disease and Framingham Risk Scores
  • Abstract Number: 260
    Risk of Cardiovascular Disease Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
  • Abstract Number: 2989
    Risk of Cardiovascular Disease Events Among Patients with Systemic Lupus Erythematosus Compared to Those with Diabetes Mellitus in a Nationwide Medicaid Cohort
  • Abstract Number: 877
    Risk of Coronary Artery Disease in Patients with Polymyalgia Rheumatica: A Systematic Review and Meta-Analysis
  • Abstract Number: 2646
    Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): A Systematic Review and Meta-Analysis
  • Abstract Number: 1195
    Risk of Hospitalized Infection Among Patients with Sarcoidosis: A Population-Based Retrospective Cohort Study
  • Abstract Number: 3066
    Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
  • Abstract Number: 1991
    Risk of Incident Diabetes Mellitus and Its Association with Disease-Modifying Antirheumatic Drugs and Statins in Rheumatoid Arthritis
  • Abstract Number: 3116
    Risk of Infections in Juvenile Idiopathic Arthritis Patients Treated with Biologic Agentsand/or Methotrexate: Results from Pharmachild Registry
  • Abstract Number: 2029
    Risk of Knee Pain, Radiographic Osteoarthritis and Knee Arthroplasty in Retired Professional Footballers Compared to the General Population 
  • Abstract Number: 2813
    Risk of Renal Failure within 10 or 20 Years of SLE Diagnosis, By Patient Characteristics
  • Abstract Number: 988
    Risk of Rheumatoid Arthritis after Transfusion of Blood from Donors Later Diagnosed with  Rheumatoid Arthritis: A Retrospective Cohort Study
  • Abstract Number: 29
    Risk of Vascular Mortality in Seniors with New-Onset Rheumatoid Arthritis
  • Abstract Number: 2939
    Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis
  • Abstract Number: 763
    Rituximab As a Corticosteroid-Sparing Agent in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 907
    Rituximab in Patients with Takayasu Arteritis: A Single Center Experience on Five Patients
  • Abstract Number: 259
    Rituximab in Refractory Cardiac Sarcoidosis – Single Center Experience
  • Abstract Number: 2904
    Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
  • Abstract Number: 387
    Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis
  • Abstract Number: 2118
    Rituximab Treated Non Responder Rheumatoid Arthritis Patients Are Generating a New Autoantibody  Repertoire
  • Abstract Number: 2088
    Rituximab Use in Pediatric Lupus Anticoagulant Hypoprothrombinemia Syndrome – Report of Three Cases and Review of the Literature
  • Abstract Number: 1955
    Rituximab Versus Azathioprine to Maintain Remission of ANCA-Associated Vasculitides (MAINRITSAN): Follow-up at 60 Months
  • Abstract Number: 817
    RNA and Protein Cargo of  Exosomes Isolated from Serum of Systemic Sclerosis Patients Induce a Profibrotic Phenotype in Cultured Normal Human Dermal Fibroblasts: A Potential Mechanism for the Initiation and Progression of a Profibrotic Phenotype in SSc
  • Abstract Number: 669
    RNA-Sequencing Reveals Sjogren’s Syndrome Anti-Ro Negative Patients Share Similar Pathways to Multiple Sclerosis Patients
  • Abstract Number: 2418
    Rnaseq Reveals Treatment-Associated Gene Expression Dynamics in Juvenile Idiopathic Arthritis CD4+ T Cells
  • Abstract Number: 2457
    Role of Hydroxychloroquine in Improving  Pregnancy Outcomes in Women with Antiphospholipid Antibodies without Other Underlying Connective Tissue Disease
  • Abstract Number: 1660
    Role of Immune System Cells and Induction of Netosis-Mediated Cell Death in the Development of Atherosclerosis in Ankylosing Spondylitis
  • Abstract Number: 469
    Role of Microbiota in Development of Autoimmune Arthritis
  • Abstract Number: 2258
    Role of NLRP12 on Disease Severity in Autoimmune Arthritis
  • Abstract Number: 2386
    Role of Pentraxin 3 in Patients with Juvenile Scleroderma
  • Abstract Number: 2808
    Role of Serum Autoantibodies in Blood Brain Barrier Damages in Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 222
    Role of Synovial Biopsy in Diagnosis of Crystal Arthropathies
  • Abstract Number: 3144
    Role of the Gut Microbiome in Modulating Arthritis Progression in Mice
  • Abstract Number: 2926
    Rorc Positive Th17, Th17/Th1, and Th17.1 Cells from the Blood of Treatment NaïVe RA Patients Differ in IL-17A but Are All Pathogenic When Co-Cultured with RA Synovial Fibroblasts
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences